8-K: Avery Dennison Announces Temporary CFO Change Due to Medical Leave

Avery Dennison's CFO, Gregory S. Lovins, has taken a medical leave of absence, and Danny G. Allouche has been appointed as Interim CFO, effective November 15, 2024.

Summary

• Avery Dennison's Senior Vice President and Chief Financial Officer, Gregory S. Lovins, began a medical leave of absence on November 14, 2024.
• Danny G. Allouche, currently Senior Vice President and Chief Strategy and Corporate Development Officer, has been appointed as Interim Chief Financial Officer, effective November 15, 2024.
• Mr. Allouche will retain his current role in addition to his new responsibilities as interim CFO.
• Mr. Allouche's compensation package will remain unchanged, including an annual base salary of approximately $450,000, a target Annual Incentive Plan opportunity of 50%, and a target annual long-term incentive opportunity of 120%.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the medical leave of the CFO is a negative event, the company's quick response in appointing an experienced interim CFO and maintaining his compensation package is a positive sign of stability.

Positives

• The company has a clear succession plan in place to ensure continuity in the CFO role.
• Danny G. Allouche has extensive experience within the company, having held various leadership positions since 2010.
• Mr. Allouche's compensation package remains unchanged, indicating stability during the interim period.

Negatives

• The medical leave of absence of the current CFO, Gregory S. Lovins, introduces uncertainty.
• The length of the interim appointment for Danny G. Allouche is not known at this time.

Risks

• The medical leave of absence of the CFO could potentially impact the company's financial operations.
• The transition to an interim CFO could create some operational challenges.
• The uncertainty surrounding the duration of the interim appointment may cause concern.

Future Outlook

The company has not provided any specific forward-looking statements regarding the CFO situation, but the appointment of an interim CFO ensures continuity.

Management Comments

• The Board of Directors elected Danny G. Allouche as the Company's Senior Vice President and Interim Chief Financial Officer.
• The Boards Talent and Compensation Committee approved an unchanged compensation package for Mr. Allouche.

Industry Context

This type of executive change is not uncommon in the corporate world, especially when dealing with unforeseen circumstances like medical leaves. The company's quick action to appoint an interim CFO demonstrates a commitment to maintaining operational stability.

Comparison to Industry Standards

• Many large corporations have succession plans in place for key executive roles, and Avery Dennison's response is consistent with this practice.
• The appointment of an internal candidate as interim CFO is a common approach to ensure a smooth transition.
• The unchanged compensation package for the interim CFO is also a typical practice to maintain stability and avoid disruption.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the CFO's medical leave but reassured by the appointment of an experienced interim CFO.
• Employees may experience some changes in leadership and reporting structures.
• Customers and suppliers are unlikely to be significantly impacted by this change.

Next Steps

• The company will likely monitor Gregory S. Lovins' medical leave and provide updates as appropriate.
• Danny G. Allouche will assume the responsibilities of the interim CFO while continuing his role as Chief Strategy and Corporate Development Officer.
• The company's annual executive compensation review process will take place in three months, which may impact the interim CFO's compensation.

Key Dates

Keywords

CFO, Interim CFO, Medical Leave, Executive Change, Corporate Governance, Financial Officer, Avery Dennison, Management Change